Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on Invested CapitalReturn on Sales

Dr Reddys Laboratories (RDY) Invested Capital (2017 - 2025)

Historic Invested Capital for Dr Reddys Laboratories (RDY) over the last 16 years, with Q4 2025 value amounting to $564.7 million.

  • Dr Reddys Laboratories' Invested Capital changed N/A to $564.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 11830.64%. This contributed to the annual value of $5.4 billion for FY2025, which is 2267.84% up from last year.
  • As of Q4 2025, Dr Reddys Laboratories' Invested Capital stood at $564.7 million.
  • Dr Reddys Laboratories' 5-year Invested Capital high stood at $4.4 billion for Q1 2024, and its period low was $80.8 million during Q3 2023.
  • For the 5-year period, Dr Reddys Laboratories' Invested Capital averaged around $955.7 million, with its median value being $417.0 million (2021).
  • In the last 5 years, Dr Reddys Laboratories' Invested Capital plummeted by 8860.08% in 2021 and then surged by 70807.98% in 2023.
  • Dr Reddys Laboratories' Invested Capital (Quarter) stood at $284.7 million in 2021, then crashed by 50.94% to $139.7 million in 2022, then crashed by 42.14% to $80.8 million in 2023, then surged by 490.56% to $477.3 million in 2024, then grew by 18.31% to $564.7 million in 2025.
  • Its Invested Capital stands at $564.7 million for Q4 2025, versus $481.3 million for Q3 2025 and $1.4 billion for Q1 2025.